Immunocore Holdings plc (IMCR)
Nasdaq: IMCR · Biological Products, (No Diagnostic Substances) · Oxfordshire, GB · filing with the SEC since 2016
Who owns Immunocore Holdings plc
As filed with the SECHolders of 5% or more
5
Wellington Management Group LLP holds 11.6% of Common Stock, as its SCHEDULE 13G/A filed Aug 13, 2026 says.
Directors and officers
11
report now, of 20 people on the record since 2024. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 5 named at left.
Holders of 5% or moreshare of the class, as filed
Wellington Management Group LLP
SCHEDULE 13G/A · filed Aug 13, 2026 · Common Stock · 10.2% in Aug 5, 2025
Jallal Bahija
SCHEDULE 13G · filed Feb 14, 2025 · Ordinary shares, nominal value of GBP0.002 per share
Primecap Management Co/ca/
SCHEDULE 13G/A · filed Aug 14, 2025 · ADR · 5.33% in Feb 13, 2025
Bellevue Group AG
SCHEDULE 13G · filed Nov 14, 2025 · Ordinary shares
Tang Capital Management, LLC
SCHEDULE 13G · filed Oct 24, 2025 · American Depositary Shares, each representing one ordinary share, nominal value GBP 0.002 per share
T. Rowe Price Investment Management, Inc.
SCHEDULE 13G/A · filed May 15, 2026 · ADR · reported falling below 5%, from 6% in Mar 6, 2026
Fmr LLC
SCHEDULE 13G/A · filed Oct 7, 2026 · COMMON STOCK · reported falling below 5%, from 8.8% in Aug 6, 2026
Vestal Point Capital, LP
SCHEDULE 13G/A · filed Aug 14, 2026 · American Depository Shares, each representing one ordinary share, nominal value 0.002 euro per share · reported falling below 5%, from 5.5% in May 15, 2026
Eli Lilly & Co.
SCHEDULE 13G/A · filed Oct 3, 2025 · Ordinary Shares · reported falling below 5%
What IMCR reports owning in othersstakes of 5% or more, and other ties
5 subsidiaries in 4 countries, from the list filed with the 10-K filed Feb 25, 2026.
Insider tradesForm 4
10sales
0purchases
6sales on a scheduled plan
4people selling
$5.6Msold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window4 of 20 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Berman David M | HEAD OF R&D | 8 | $7.4M | 7 | 0 | $0 |
| Jallal Bahija | CHIEF EXECUTIVE OFFICER | 1 | $400,000 | 0 | 0 | $0 |
| St Leger Tina Amber | CHIEF HR OFFICER | 1 | $0 | 0 | 0 | $0 |
| Goll John | SVP, FINANCE & CAO | 1 | $0 | 0 | 0 | $0 |